Medical Science Liaison - Ohio/Kentucky
Natera- Full Time
- Junior (1 to 2 years)
Employment Type: Full time
Location Type: Field-based (Heartland territory: MO and IN regions of the US)
Tempus is seeking a high-performing and experienced Medical Science Liaison (MSL) or Senior Medical Science Liaison (Sr. MSL) to support the commercial and educational objectives of the company. This field-based role requires a strong clinical and scientific background in oncology and genomic testing. The MSL will be responsible for educating healthcare providers about Tempus assays and technologies, leveraging the company's proprietary platform that connects real-world evidence to deliver actionable insights for physicians.
Tempus is driven by a passion for precision medicine and advancing the healthcare industry. Our proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Tempus is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.